HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoko Matsumoto Selected Research

Hematoxylin (Haematoxylon)

11/2017Trehalose Liposomes Suppress the Growth of Tumors on Human Lung Carcinoma-bearing Mice by Induction of Apoptosis In Vivo.
7/2010Histological bioanalysis for therapeutic effects of hybrid liposomes on the hepatic metastasis of colon carcinoma in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoko Matsumoto Research Topics

Disease

54Neoplasms (Cancer)
04/2024 - 04/2002
24Carcinoma (Carcinomatosis)
10/2020 - 04/2002
13Neoplasm Metastasis (Metastasis)
12/2019 - 04/2009
9Endometrial Neoplasms (Endometrial Cancer)
10/2022 - 01/2007
9Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2021 - 01/2013
7Macular Degeneration (Age-Related Maculopathy)
10/2008 - 01/2002
6Breast Neoplasms (Breast Cancer)
11/2020 - 02/2006
5Carcinogenesis
10/2022 - 01/2012
4Lung Neoplasms (Lung Cancer)
01/2023 - 01/2016
4Colorectal Neoplasms (Colorectal Cancer)
11/2018 - 11/2012
4Choroidal Neovascularization
10/2008 - 09/2006
3Hepatocellular Carcinoma (Hepatoma)
04/2024 - 11/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2016
3Infections
11/2021 - 02/2014
3Body Weight (Weight, Body)
10/2020 - 04/2019
3Rheumatoid Arthritis
07/2015 - 01/2011
3Atrophy
07/2014 - 05/2004
3Lymphoma (Lymphomas)
04/2009 - 06/2006
2Adenocarcinoma of Lung
04/2024 - 04/2002
2Lung Diseases (Lung Disease)
11/2021 - 06/2018
2Hypersensitivity (Allergy)
11/2020 - 01/2013
2Renal Cell Carcinoma (Grawitz Tumor)
10/2020 - 02/2010
2Ascites
10/2020 - 04/2019
2Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 04/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 01/2018
2Lymphatic Metastasis
04/2016 - 01/2007
2Arthritis (Polyarthritis)
07/2015 - 01/2011
2Neuroblastoma
04/2011 - 01/2011
2Leukemia
03/2011 - 06/2005
2Macular Edema
07/2010 - 04/2007
2Polypoidal Choroidal Vasculopathy
07/2007 - 09/2006
2Melanoma (Melanoma, Malignant)
09/2004 - 01/2003
1Nausea
05/2024
1Vomiting
05/2024
1Hemiplegia (Spastic Hemiplegia)
08/2023
1Stroke (Strokes)
08/2023

Drug/Important Bio-Agent (IBA)

47Liposomes (Liposome)IBA
04/2024 - 04/2002
28Dimyristoylphosphatidylcholine (DMPC)IBA
03/2021 - 04/2002
17Therapeutic UsesIBA
01/2019 - 04/2009
11Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2019 - 11/2002
9Ether (Diethyl Ether)IBA
01/2019 - 11/2002
7Proteins (Proteins, Gene)FDA Link
10/2022 - 03/2013
5Biomarkers (Surrogate Marker)IBA
04/2024 - 03/2014
5TrehaloseIBA
03/2021 - 01/2013
51-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2008 - 09/2006
4polyoxyethylene(25)dodecyl etherIBA
10/2018 - 11/2012
4Surface-Active Agents (Surfactants)IBA
01/2016 - 04/2002
4polyoxyethylene (23) dodecyletherIBA
07/2015 - 03/2005
4Retinaldehyde (Retinal)IBA
02/2008 - 05/2004
3Histone MethyltransferasesIBA
10/2022 - 01/2019
3DNA (Deoxyribonucleic Acid)IBA
10/2022 - 03/2014
3LipidsIBA
06/2021 - 09/2008
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 04/2007
3Bevacizumab (Avastin)FDA Link
06/2021 - 04/2007
3dihydroceramide desaturaseIBA
11/2019 - 01/2016
3Messenger RNA (mRNA)IBA
10/2019 - 01/2007
3UbiquitinIBA
06/2016 - 04/2006
3Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2014 - 03/2008
3Polysorbates (PSML)FDA Link
07/2008 - 04/2002
2IntegrinsIBA
01/2023 - 01/2020
2Histones (Histone)IBA
10/2022 - 01/2019
2Small Interfering RNA (siRNA)IBA
10/2022 - 10/2016
2Carboplatin (JM8)FDA LinkGeneric
11/2020 - 01/2013
2EverolimusFDA Link
10/2020 - 01/2012
2Monoclonal AntibodiesIBA
09/2020 - 04/2007
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2020 - 03/2014
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2019 - 01/2012
2ChloridesIBA
01/2019 - 01/2014
2diethanolamineIBA
01/2019 - 01/2014
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2019 - 03/2014
2Estrogens (Estrogen)FDA Link
11/2018 - 01/2016
2Fluorescent Dyes (Fluorescent Probes)IBA
11/2018 - 10/2018
2Caspase 3 (Caspase-3)IBA
01/2018 - 06/2005
2Eosine Yellowish-(YS) (Eosin)IBA
11/2017 - 07/2010
2Hematoxylin (Haematoxylon)IBA
11/2017 - 07/2010
2MicellesIBA
10/2016 - 06/2016
2Antineoplastic Agents (Antineoplastics)IBA
06/2016 - 09/2008
2Oncogene Proteins (Oncogene Protein)IBA
04/2015 - 07/2008
2Phospholipids (Phosphatides)FDA LinkGeneric
01/2011 - 02/2006
2Fluorescein (Funduscein)FDA LinkGeneric
07/2010 - 01/2007
2Docosahexaenoic AcidsIBA
07/2008 - 03/2008
2sorbitan monooleate (Span 80)IBA
07/2008 - 03/2008
2CaspasesIBA
07/2008 - 02/2006
2Verteporfin (Visudyne)FDA Link
07/2007 - 09/2006
2Polidocanol (Laureth)FDA Link
03/2005 - 01/2003
1EmeticsIBA
05/2024
1NectinsIBA
04/2024
1Lysine (L-Lysine)FDA Link
10/2022

Therapy/Procedure

14Drug Therapy (Chemotherapy)
05/2024 - 06/2006
14Therapeutics
08/2023 - 09/2006
5Photochemotherapy (Photodynamic Therapy)
10/2008 - 09/2006
4Intravenous Injections
10/2016 - 07/2010
4Aftercare (After-Treatment)
09/2014 - 03/2008
2Palliative Care (Palliative Therapy)
09/2022 - 05/2010
2Radiotherapy
11/2019 - 01/2019
2Hysterectomy
08/2019 - 04/2016
2Intravenous Administration
11/2018 - 10/2018
2Precision Medicine
11/2018 - 10/2018
2Retreatment
01/2013 - 07/2010
2Vitrectomy
02/2004 - 01/2002